Published in Obesity and Diabetes Week, August 14th, 2006
In a recent report, researchers in Italy conducted a study "to investigate the effects of propionyl L-carnitine (PLC) on clinical and functional parameters, and markers of the overall oxidation state in patients with peripheral arterial disease (PAD) associated with noninsulin-dependent diabetes mellitus (NIDDM). Randomised, double-blind, clinical trial, conducted in the Unit of Medical Angiology of the University of Catania."
"Seventy-four patients with NIDDM-associated PAD were treated with PLC (2 g/day) or placebo...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week